Indian stock market is expected to maintain its upward momentum, targeting Nifty 50 at 28,700 level. However, this upward ...

a subsidiary company of Laurus Labs. The company completed the said transaction on December 20. The Competition Commission of ...

It has set a target of Rs 315. CMP: Rs 231.50 on NSE. Bajaj Broking has recommended pharma company Laurus Labs shares to BUY ...

Eight Roads Ventures and F-Prime Capital have partnered with Laurus Labs to infuse Rs 120 crore into Laurus Bio, enabling expansion in fermentation-based manufacturing.

Laurus Labs Ltd is quoting at Rs 582.25, up 0.27% on the day as on 12:44 IST on the NSE. The stock is up 54.71% in last one year as compared to a 17.19% jump in NIFTY and a 37.94% jump in the Nifty ...

Laurus Labs Ltd is quoting at Rs 577.25, up 1.78% on the day as on 12:49 IST on the NSE. The stock is up 52.21% in last one year as compared to a 16.91% gain in NIFTY and a 38.53% gain in the Nifty ...

Laurus Labs Ltd share price was up by 1.71% from the previous closing price of ₹563.80. Who are peers of Laurus Labs Ltd? The peers of Laurus Labs Ltd are Sun Pharmaceuticals Industries Ltd ...

Laurus Labs is a science-led, fully integrated pharmaceutical and biotechnology manufacturing company with a leadership position in generic active pharmaceutical ingredients (APIs) in selected ...

Catch up on the latest stock market news! Today, we cover key developments including Aurobindo Pharma’s marketing authorization for its biosimilar, Fortis Healthcare's stake acquisition in Agilus ...

The shares of Laurus Labs Limited were trading at ₹580.05 up by ₹12.90 or 2.27 per cent on the NSE today at 10.55 am. The shares hit the 52-week high today morning at ₹581.70. Laurus Labs ...